Search Results - "Siegmund, B"
-
1
Peripheral tumor necrosis factor production is a predictor for remission under adalimumab in Crohn’s disease
Published in Clinical gastroenterology and hepatology (02-11-2024)Get full text
Journal Article -
2
Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce
Published in Journal of Crohn's and colitis (21-10-2020)“…Abstract Our knowledge of COVID-19 is changing and evolving rapidly, with novel insights and recommendations, almost on a daily basis. It behooves the medical…”
Get full text
Journal Article -
3
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
Published in Annals of the rheumatic diseases (01-03-2017)“…To investigate the risk of developing lower intestinal perforations (LIPs) in patients with rheumatoid arthritis (RA) treated with tocilizumab (TCZ). In 13 310…”
Get more information
Journal Article -
4
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study
Published in Alimentary pharmacology & therapeutics (01-12-2016)“…Summary Background Vedolizumab, a monoclonal antibody targeting the α4β7‐integrin, is effective in inducing and maintaining clinical remission in Crohn's…”
Get full text
Journal Article -
5
Reconstruction of the temporomandibular joint: a comparison between prefabricated and customized alloplastic prosthetic total joint systems
Published in International journal of oral and maxillofacial surgery (01-08-2019)“…The implantation of an alloplastic total temporomandibular joint (TMJ) prosthesis is an innovative approach for the treatment of end-stage TMJ disorders. Two…”
Get full text
Journal Article -
6
Faecal microbiota transplantation—A clinical view
Published in International journal of medical microbiology (01-08-2016)“…Highlights • Faecal microbiota transplantation is curative for Clostridium difficile infection. • The intestinal microbiota in inflammatory bowel disease has a…”
Get full text
Journal Article -
7
European Study on Orthopaedic Status of haemophilia patients with inhibitors
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-09-2007)“…Development of inhibitors against factor VIII (FVIII) or factor IX (FIX) in haemophilia patients is one of the most serious complications of repeated exposure…”
Get full text
Journal Article -
8
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review
Published in Schmerz (Berlin, Germany) (01-02-2016)“…The medical use of cannabis is discussed in gastroenterology for inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and chronic pancreatitis. A…”
Get full text
Journal Article -
9
Adipokine signaling in inflammatory bowel disease
Published in Inflammatory bowel diseases (01-12-2009)“…: While the incidence of inflammatory bowel disease (IBD) is still increasing, the etiology has not finally been dissected. The main hypothesis suggests that…”
Get full text
Journal Article -
10
Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon
Published in Mucosal immunology (01-03-2018)“…Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to…”
Get full text
Journal Article -
11
P766 No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE
Published in Journal of Crohn's and colitis (24-01-2024)“…Abstract Background In the SPARE trial, the discontinuation of infliximab (IFX) in patients with Crohn’s disease (CD) in sustained remission under combination…”
Get full text
Journal Article -
12
Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon
Published in Mucosal immunology (01-03-2018)“…This corrects the article DOI: 10.1038/mi.2017.66…”
Get full text
Journal Article -
13
Spatio-temporal variability of sugarcane fields and recommendations for yield forecast using NDVI
Published in International journal of remote sensing (01-06-2010)“…Sugarcane is a semi-perennial grass whose cultivation is characterized by an extended harvest season lasting several months leading to very high…”
Get full text
Journal Article -
14
High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders
Published in Neurogastroenterology and motility (01-06-2018)“…Background Antineuronal antibodies can be associated with both gastrointestinal (GI) and brain disorders. For example, antibodies against the potassium channel…”
Get full text
Journal Article -
15
Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence
Published in Journal of Crohn's and colitis (01-09-2017)“…Abstract Background and Aim Recent observational studies document that non-adherence to mesalamine therapy during remission is frequent. We aimed to…”
Get full text
Journal Article -
16
Architectural and functional alterations of the small intestinal mucosa in classical Whipple’s disease
Published in Mucosal immunology (01-11-2017)“…Classical Whipple’s disease (CWD) affects the gastrointestinal tract and rather elicits regulatory than inflammatory immune reactions. Mechanisms of…”
Get full text
Journal Article -
17
Mesenteric fat—control site for bacterial translocation in colitis?
Published in Mucosal immunology (01-09-2012)“…In Crohn's disease bacteria could be detected in the adjacent mesenteric fat characterized by hypertrophy of unknown function. This study aimed to define…”
Get full text
Journal Article -
18
Imbalance between interleukin‐1 agonists and antagonists: relationship to severity of inflammatory bowel disease
Published in Clinical and experimental immunology (01-11-2004)“…SUMMARY Interleukin (IL)‐1 is a key mediator in the pathogenesis of inflammatory bowel disease (IBD). Naturally occurring IL‐1 modulators include IL‐1 receptor…”
Get full text
Journal Article -
19
Co‐morbidities and bleeding in elderly patients with haemophilia—A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-09-2017)“…Background Nowadays patients with haemophilia survive longer due to improvements in haemophilia care. It has been hypothesized that the bleeding type and…”
Get full text
Journal Article -
20